1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasma-derived Factor VIII Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Plasma-derived Factor VIII by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Plasma-derived Factor VIII by Country/Region, 2017, 2022 & 2028
2.2 Plasma-derived Factor VIII Segment by Type
2.2.1 200IU
2.2.2 250IU
2.3 Plasma-derived Factor VIII Sales by Type
2.3.1 Global Plasma-derived Factor VIII Sales Market Share by Type (2017-2022)
2.3.2 Global Plasma-derived Factor VIII Revenue and Market Share by Type (2017-2022)
2.3.3 Global Plasma-derived Factor VIII Sale Price by Type (2017-2022)
2.4 Plasma-derived Factor VIII Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Plasma-derived Factor VIII Sales by Application
2.5.1 Global Plasma-derived Factor VIII Sale Market Share by Application (2017-2022)
2.5.2 Global Plasma-derived Factor VIII Revenue and Market Share by Application (2017-2022)
2.5.3 Global Plasma-derived Factor VIII Sale Price by Application (2017-2022)
3 Global Plasma-derived Factor VIII by Company
3.1 Global Plasma-derived Factor VIII Breakdown Data by Company
3.1.1 Global Plasma-derived Factor VIII Annual Sales by Company (2020-2022)
3.1.2 Global Plasma-derived Factor VIII Sales Market Share by Company (2020-2022)
3.2 Global Plasma-derived Factor VIII Annual Revenue by Company (2020-2022)
3.2.1 Global Plasma-derived Factor VIII Revenue by Company (2020-2022)
3.2.2 Global Plasma-derived Factor VIII Revenue Market Share by Company (2020-2022)
3.3 Global Plasma-derived Factor VIII Sale Price by Company
3.4 Key Manufacturers Plasma-derived Factor VIII Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Plasma-derived Factor VIII Product Location Distribution
3.4.2 Players Plasma-derived Factor VIII Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Plasma-derived Factor VIII by Geographic Region
4.1 World Historic Plasma-derived Factor VIII Market Size by Geographic Region (2017-2022)
4.1.1 Global Plasma-derived Factor VIII Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Plasma-derived Factor VIII Annual Revenue by Geographic Region
4.2 World Historic Plasma-derived Factor VIII Market Size by Country/Region (2017-2022)
4.2.1 Global Plasma-derived Factor VIII Annual Sales by Country/Region (2017-2022)
4.2.2 Global Plasma-derived Factor VIII Annual Revenue by Country/Region
4.3 Americas Plasma-derived Factor VIII Sales Growth
4.4 APAC Plasma-derived Factor VIII Sales Growth
4.5 Europe Plasma-derived Factor VIII Sales Growth
4.6 Middle East & Africa Plasma-derived Factor VIII Sales Growth
5 Americas
5.1 Americas Plasma-derived Factor VIII Sales by Country
5.1.1 Americas Plasma-derived Factor VIII Sales by Country (2017-2022)
5.1.2 Americas Plasma-derived Factor VIII Revenue by Country (2017-2022)
5.2 Americas Plasma-derived Factor VIII Sales by Type
5.3 Americas Plasma-derived Factor VIII Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasma-derived Factor VIII Sales by Region
6.1.1 APAC Plasma-derived Factor VIII Sales by Region (2017-2022)
6.1.2 APAC Plasma-derived Factor VIII Revenue by Region (2017-2022)
6.2 APAC Plasma-derived Factor VIII Sales by Type
6.3 APAC Plasma-derived Factor VIII Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Plasma-derived Factor VIII by Country
7.1.1 Europe Plasma-derived Factor VIII Sales by Country (2017-2022)
7.1.2 Europe Plasma-derived Factor VIII Revenue by Country (2017-2022)
7.2 Europe Plasma-derived Factor VIII Sales by Type
7.3 Europe Plasma-derived Factor VIII Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Plasma-derived Factor VIII by Country
8.1.1 Middle East & Africa Plasma-derived Factor VIII Sales by Country (2017-2022)
8.1.2 Middle East & Africa Plasma-derived Factor VIII Revenue by Country (2017-2022)
8.2 Middle East & Africa Plasma-derived Factor VIII Sales by Type
8.3 Middle East & Africa Plasma-derived Factor VIII Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Plasma-derived Factor VIII
10.3 Manufacturing Process Analysis of Plasma-derived Factor VIII
10.4 Industry Chain Structure of Plasma-derived Factor VIII
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Plasma-derived Factor VIII Distributors
11.3 Plasma-derived Factor VIII Customer
12 World Forecast Review for Plasma-derived Factor VIII by Geographic Region
12.1 Global Plasma-derived Factor VIII Market Size Forecast by Region
12.1.1 Global Plasma-derived Factor VIII Forecast by Region (2023-2028)
12.1.2 Global Plasma-derived Factor VIII Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Plasma-derived Factor VIII Forecast by Type
12.7 Global Plasma-derived Factor VIII Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Plasma-derived Factor VIII Product Offered
13.1.3 Takeda Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Octapharma
13.2.1 Octapharma Company Information
13.2.2 Octapharma Plasma-derived Factor VIII Product Offered
13.2.3 Octapharma Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Octapharma Main Business Overview
13.2.5 Octapharma Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Plasma-derived Factor VIII Product Offered
13.3.3 CSL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Plasma-derived Factor VIII Product Offered
13.4.3 Grifols Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 Greencross
13.5.1 Greencross Company Information
13.5.2 Greencross Plasma-derived Factor VIII Product Offered
13.5.3 Greencross Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Greencross Main Business Overview
13.5.5 Greencross Latest Developments
13.6 Kedrion
13.6.1 Kedrion Company Information
13.6.2 Kedrion Plasma-derived Factor VIII Product Offered
13.6.3 Kedrion Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Kedrion Main Business Overview
13.6.5 Kedrion Latest Developments
13.7 BPL
13.7.1 BPL Company Information
13.7.2 BPL Plasma-derived Factor VIII Product Offered
13.7.3 BPL Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 BPL Main Business Overview
13.7.5 BPL Latest Developments
13.8 Hualan Bio
13.8.1 Hualan Bio Company Information
13.8.2 Hualan Bio Plasma-derived Factor VIII Product Offered
13.8.3 Hualan Bio Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hualan Bio Main Business Overview
13.8.5 Hualan Bio Latest Developments
13.9 RAAS
13.9.1 RAAS Company Information
13.9.2 RAAS Plasma-derived Factor VIII Product Offered
13.9.3 RAAS Plasma-derived Factor VIII Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 RAAS Main Business Overview
13.9.5 RAAS Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Plasma-derived Factor VIII Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Plasma-derived Factor VIII Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 200IU
Table 4. Major Players of 250IU
Table 5. Global Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 6. Global Plasma-derived Factor VIII Sales Market Share by Type (2017-2022)
Table 7. Global Plasma-derived Factor VIII Revenue by Type (2017-2022) & ($ million)
Table 8. Global Plasma-derived Factor VIII Revenue Market Share by Type (2017-2022)
Table 9. Global Plasma-derived Factor VIII Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 11. Global Plasma-derived Factor VIII Sales Market Share by Application (2017-2022)
Table 12. Global Plasma-derived Factor VIII Revenue by Application (2017-2022)
Table 13. Global Plasma-derived Factor VIII Revenue Market Share by Application (2017-2022)
Table 14. Global Plasma-derived Factor VIII Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Plasma-derived Factor VIII Sales by Company (2020-2022) & (K Units)
Table 16. Global Plasma-derived Factor VIII Sales Market Share by Company (2020-2022)
Table 17. Global Plasma-derived Factor VIII Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Plasma-derived Factor VIII Revenue Market Share by Company (2020-2022)
Table 19. Global Plasma-derived Factor VIII Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Plasma-derived Factor VIII Producing Area Distribution and Sales Area
Table 21. Players Plasma-derived Factor VIII Products Offered
Table 22. Plasma-derived Factor VIII Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Plasma-derived Factor VIII Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Plasma-derived Factor VIII Sales Market Share Geographic Region (2017-2022)
Table 27. Global Plasma-derived Factor VIII Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Plasma-derived Factor VIII Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Plasma-derived Factor VIII Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Plasma-derived Factor VIII Sales Market Share by Country/Region (2017-2022)
Table 31. Global Plasma-derived Factor VIII Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Plasma-derived Factor VIII Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Plasma-derived Factor VIII Sales by Country (2017-2022) & (K Units)
Table 34. Americas Plasma-derived Factor VIII Sales Market Share by Country (2017-2022)
Table 35. Americas Plasma-derived Factor VIII Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Plasma-derived Factor VIII Revenue Market Share by Country (2017-2022)
Table 37. Americas Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 38. Americas Plasma-derived Factor VIII Sales Market Share by Type (2017-2022)
Table 39. Americas Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 40. Americas Plasma-derived Factor VIII Sales Market Share by Application (2017-2022)
Table 41. APAC Plasma-derived Factor VIII Sales by Region (2017-2022) & (K Units)
Table 42. APAC Plasma-derived Factor VIII Sales Market Share by Region (2017-2022)
Table 43. APAC Plasma-derived Factor VIII Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Plasma-derived Factor VIII Revenue Market Share by Region (2017-2022)
Table 45. APAC Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 46. APAC Plasma-derived Factor VIII Sales Market Share by Type (2017-2022)
Table 47. APAC Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 48. APAC Plasma-derived Factor VIII Sales Market Share by Application (2017-2022)
Table 49. Europe Plasma-derived Factor VIII Sales by Country (2017-2022) & (K Units)
Table 50. Europe Plasma-derived Factor VIII Sales Market Share by Country (2017-2022)
Table 51. Europe Plasma-derived Factor VIII Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Plasma-derived Factor VIII Revenue Market Share by Country (2017-2022)
Table 53. Europe Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 54. Europe Plasma-derived Factor VIII Sales Market Share by Type (2017-2022)
Table 55. Europe Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 56. Europe Plasma-derived Factor VIII Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Plasma-derived Factor VIII Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Plasma-derived Factor VIII Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Plasma-derived Factor VIII Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Plasma-derived Factor VIII Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Plasma-derived Factor VIII Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Plasma-derived Factor VIII
Table 66. Key Market Challenges & Risks of Plasma-derived Factor VIII
Table 67. Key Industry Trends of Plasma-derived Factor VIII
Table 68. Plasma-derived Factor VIII Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Plasma-derived Factor VIII Distributors List
Table 71. Plasma-derived Factor VIII Customer List
Table 72. Global Plasma-derived Factor VIII Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Plasma-derived Factor VIII Sales Market Forecast by Region
Table 74. Global Plasma-derived Factor VIII Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Plasma-derived Factor VIII Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Plasma-derived Factor VIII Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Plasma-derived Factor VIII Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Plasma-derived Factor VIII Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Plasma-derived Factor VIII Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Plasma-derived Factor VIII Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Plasma-derived Factor VIII Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Plasma-derived Factor VIII Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Plasma-derived Factor VIII Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Plasma-derived Factor VIII Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Plasma-derived Factor VIII Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Plasma-derived Factor VIII Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Plasma-derived Factor VIII Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Plasma-derived Factor VIII Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Plasma-derived Factor VIII Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Plasma-derived Factor VIII Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Plasma-derived Factor VIII Revenue Market Share Forecast by Application (2023-2028)
Table 92. Takeda Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 93. Takeda Plasma-derived Factor VIII Product Offered
Table 94. Takeda Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. Octapharma Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 98. Octapharma Plasma-derived Factor VIII Product Offered
Table 99. Octapharma Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Octapharma Main Business
Table 101. Octapharma Latest Developments
Table 102. CSL Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 103. CSL Plasma-derived Factor VIII Product Offered
Table 104. CSL Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. CSL Main Business
Table 106. CSL Latest Developments
Table 107. Grifols Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 108. Grifols Plasma-derived Factor VIII Product Offered
Table 109. Grifols Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Grifols Main Business
Table 111. Grifols Latest Developments
Table 112. Greencross Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 113. Greencross Plasma-derived Factor VIII Product Offered
Table 114. Greencross Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Greencross Main Business
Table 116. Greencross Latest Developments
Table 117. Kedrion Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 118. Kedrion Plasma-derived Factor VIII Product Offered
Table 119. Kedrion Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Kedrion Main Business
Table 121. Kedrion Latest Developments
Table 122. BPL Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 123. BPL Plasma-derived Factor VIII Product Offered
Table 124. BPL Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. BPL Main Business
Table 126. BPL Latest Developments
Table 127. Hualan Bio Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 128. Hualan Bio Plasma-derived Factor VIII Product Offered
Table 129. Hualan Bio Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Hualan Bio Main Business
Table 131. Hualan Bio Latest Developments
Table 132. RAAS Basic Information, Plasma-derived Factor VIII Manufacturing Base, Sales Area and Its Competitors
Table 133. RAAS Plasma-derived Factor VIII Product Offered
Table 134. RAAS Plasma-derived Factor VIII Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. RAAS Main Business
Table 136. RAAS Latest Developments
List of Figures
Figure 1. Picture of Plasma-derived Factor VIII
Figure 2. Plasma-derived Factor VIII Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Plasma-derived Factor VIII Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Plasma-derived Factor VIII Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Plasma-derived Factor VIII Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 200IU
Figure 10. Product Picture of 250IU
Figure 11. Global Plasma-derived Factor VIII Sales Market Share by Type in 2021
Figure 12. Global Plasma-derived Factor VIII Revenue Market Share by Type (2017-2022)
Figure 13. Plasma-derived Factor VIII Consumed in Hospital
Figure 14. Global Plasma-derived Factor VIII Market: Hospital (2017-2022) & (K Units)
Figure 15. Plasma-derived Factor VIII Consumed in Pharmacy
Figure 16. Global Plasma-derived Factor VIII Market: Pharmacy (2017-2022) & (K Units)
Figure 17. Global Plasma-derived Factor VIII Sales Market Share by Application (2017-2022)
Figure 18. Global Plasma-derived Factor VIII Revenue Market Share by Application in 2021
Figure 19. Plasma-derived Factor VIII Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Plasma-derived Factor VIII Revenue Market Share by Company in 2021
Figure 21. Global Plasma-derived Factor VIII Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Plasma-derived Factor VIII Revenue Market Share by Geographic Region in 2021
Figure 23. Global Plasma-derived Factor VIII Sales Market Share by Region (2017-2022)
Figure 24. Global Plasma-derived Factor VIII Revenue Market Share by Country/Region in 2021
Figure 25. Americas Plasma-derived Factor VIII Sales 2017-2022 (K Units)
Figure 26. Americas Plasma-derived Factor VIII Revenue 2017-2022 ($ Millions)
Figure 27. APAC Plasma-derived Factor VIII Sales 2017-2022 (K Units)
Figure 28. APAC Plasma-derived Factor VIII Revenue 2017-2022 ($ Millions)
Figure 29. Europe Plasma-derived Factor VIII Sales 2017-2022 (K Units)
Figure 30. Europe Plasma-derived Factor VIII Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Plasma-derived Factor VIII Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Plasma-derived Factor VIII Revenue 2017-2022 ($ Millions)
Figure 33. Americas Plasma-derived Factor VIII Sales Market Share by Country in 2021
Figure 34. Americas Plasma-derived Factor VIII Revenue Market Share by Country in 2021
Figure 35. United States Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Plasma-derived Factor VIII Sales Market Share by Region in 2021
Figure 40. APAC Plasma-derived Factor VIII Revenue Market Share by Regions in 2021
Figure 41. China Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Plasma-derived Factor VIII Sales Market Share by Country in 2021
Figure 48. Europe Plasma-derived Factor VIII Revenue Market Share by Country in 2021
Figure 49. Germany Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Plasma-derived Factor VIII Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Plasma-derived Factor VIII Revenue Market Share by Country in 2021
Figure 56. Egypt Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Plasma-derived Factor VIII Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Plasma-derived Factor VIII in 2021
Figure 62. Manufacturing Process Analysis of Plasma-derived Factor VIII
Figure 63. Industry Chain Structure of Plasma-derived Factor VIII
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Please ask for List of Figures. Request Sample Report